Drugs that target malignant cells increase life expectancy in advanced breast cancer

[News]

Clinical studies show that new drugs that target malignant cells of HER2-positive breast cancer, such as Pertuzumab and Trastuzumab Emtansine (T-DM1), increase life expectancy in patients with advanced breast cancer.

More... (http://www.news-medical.net/news/20151105/Drugs-that-target-malignant-cells-increase-life-expectancy-in-advanced-breast-cancer-patients.aspx)